Prostaglandin E1 treatment of congenital heart disease with pulmonary hypertension Effect.doc

Prostaglandin E1 treatment of congenital heart disease with pulmonary hypertension Effect.doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Prostaglandin E1 treatment of congenital heart disease with pulmonary hypertension Effect

 PAGE \* MERGEFORMAT 7 Prostaglandin E1 treatment of congenital heart disease with pulmonary hypertension Effect Author: Kung-bin, Zhang Zhiyong, Su scientist, Su Xia Keywords:: Congenital heart disease; pulmonary hypertension; prostaglandin E1 [Abstract] Objective To observe the prostaglandin E1 on pulmonary hypertension in congenital heart disease with the hemodynamic effects. Methods 60 patients with congenital heart disease with pulmonary hypertension were randomly divided into treatment group and control group, control group, 30 cases of conventional therapy, the treatment group 30 cases on the basis of conventional therapy with prostaglandin E1 treatment. Results of clinical symptoms, mean pulmonary artery pressure mPAP, arterial partial pressure of oxygen, arterial oxygen saturation has improved significantly. Conclusion PGE1 can significantly improve the clinical symptoms, a significant reduction in mPAP, to improve arterial oxygen and arterial oxygen saturation, pulmonary hypertension with congenital heart disease treatment effective. [Keywords:] congenital heart disease; pulmonary hypertension; prostaglandin E1 A study of PGE1 in treatment of pulmonary hypertension associated with congenital heart defect [Abstract] Objective To evaluate the effect of prostaglandin E1 with congenital heart defects and pulmonary hypertension.Methods 60 patients with congenital heart disease and pulmonary hypertension were randomly divided into therapeutic group and control group (30 case) were traditionally treated and the therapeutic group ( 30 case) were treated with prostaglandin E1 based on the traditional therapy.Results after administration of PGE1, the mean pulmonary artery pressure (mPAP) was significantly reduced, the PaO2 and SaO2 were significantly increased.Conclusion Prostaglandin E1 therapy have effetive on pulmonary hypertension associated with congenital heart defect. [Keywords:] congenital heart defect; prostaglandin E

文档评论(0)

hhuiws1482 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档